Function of GSK‑3 signaling in spinal cord injury (Review)
- Authors:
- Xiong Dong
- Hongxiang Hong
- Zhiming Cui
-
Affiliations: Department of Spinal Surgery, The Second Affiliated Hospital of Nantong University, Nantong, Jiangsu 226001, P.R. China - Published online on: October 3, 2023 https://doi.org/10.3892/etm.2023.12240
- Article Number: 541
-
Copyright: © Dong et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
This article is mentioned in:
Abstract
 |
 |
 |
|
Ahuja CS, Wilson JR, Nori S, Kotter MRN, Druschel C, Curt A and Fehlings MG: Traumatic spinal cord injury. Nat Rev Dis Primers. 3(17018)2017.PubMed/NCBI View Article : Google Scholar | |
|
Silva NA, Sousa N, Reis RL and Salgado AJ: From basics to clinical: A comprehensive review on spinal cord injury. Prog Neurobiol. 114:25–57. 2014.PubMed/NCBI View Article : Google Scholar | |
|
Vismara I, Papa S, Veneruso V, Mauri E, Mariani A, De Paola M, Affatato R, Rossetti A, Sponchioni M, Moscatelli D, et al: Selective modulation of A1 astrocytes by drug-loaded nano-structured gel in spinal cord injury. ACS Nano. 14:360–371. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Huang X, Gu YK, Cheng XY and Su ZD: Astrocytes as therapeutic targets after spinal cord injury. Sheng Li Xue Bao. 69:794–804. 2017.PubMed/NCBI(In Chinese). | |
|
Erlich S, Alexandrovich A, Shohami E and Pinkas-Kramarski R: Rapamycin is a neuroprotective treatment for traumatic brain injury. Neurobiol Dis. 26:86–93. 2007.PubMed/NCBI View Article : Google Scholar | |
|
Wu Q, Li YL, Ning GZ, Feng SQ, Chu TC, Li Y, Hao Y and Wu QL: Epidemiology of traumatic cervical spinal cord injury in Tianjin, China. Spinal Cord. 50:740–744. 2012.PubMed/NCBI View Article : Google Scholar | |
|
McKinley WO, Seel RT and Hardman JT: Nontraumatic spinal cord injury: Incidence, epidemiology, and functional outcome. Arch Phys Med Rehabil. 80:619–623. 1999.PubMed/NCBI View Article : Google Scholar | |
|
Lu P, Wang Y, Graham L, McHale K, Gao M, Wu D, Brock J, Blesch A, Rosenzweig ES, Havton LA, et al: Long-distance growth and connectivity of neural stem cells after severe spinal cord injury. Cell. 150:1264–1273. 2012.PubMed/NCBI View Article : Google Scholar | |
|
Mar FM, Simões AR, Rodrigo IS and Sousa MM: Inhibitory injury signaling represses axon regeneration after dorsal root injury. Mol Neurobiol. 53:4596–4605. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Prinz M and Priller J: The role of peripheral immune cells in the CNS in steady state and disease. Nat Neurosci. 20:136–144. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Kim YS, Choi J and Yoon BE: Neuron-glia interactions in neurodevelopmental disorders. Cells. 9(2176)2020.PubMed/NCBI View Article : Google Scholar | |
|
Pellerin L, Bouzier-Sore AK, Aubert A, Serres S, Merle M, Costalat R and Magistretti PJ: Activity-dependent regulation of energy metabolism by astrocytes: An update. Glia. 55:1251–1262. 2007.PubMed/NCBI View Article : Google Scholar | |
|
Taveggia C: Schwann cells-axon interaction in myelination. Curr Opin Neurobiol. 39:24–29. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Casano AM and Peri F: Microglia: Multitasking specialists of the brain. Dev Cell. 32:469–477. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Norenberg MD, Smith J and Marcillo A: The pathology of human spinal cord injury: Defining the problems. J Neurotrauma. 21:429–440. 2004.PubMed/NCBI View Article : Google Scholar | |
|
Sofroniew MV: Molecular dissection of reactive astrogliosis and glial scar formation. Trends Neurosci. 32:638–647. 2009.PubMed/NCBI View Article : Google Scholar | |
|
Alizadeh A, Dyck SM and Karimi-Abdolrezaee S: Traumatic spinal cord injury: An overview of pathophysiology, models and acute injury mechanisms. Front Neurol. 10(282)2019.PubMed/NCBI View Article : Google Scholar | |
|
Wasner G, Naleschinski D and Baron R: A role for peripheral afferents in the pathophysiology and treatment of at-level neuropathic pain in spinal cord injury? A case report. Pain. 131:219–225. 2007.PubMed/NCBI View Article : Google Scholar | |
|
Anjum A, Yazid MD, Fauzi Daud M, Idris J, Ng AMH, Selvi Naicker A, Ismail OHR, Athi Kumar RK and Lokanathan Y: Spinal cord injury: Pathophysiology, multimolecular interactions, and underlying recovery mechanisms. Int J Mol Sci. 21(7533)2020.PubMed/NCBI View Article : Google Scholar | |
|
Nickel M and Gu C: Regulation of central nervous system myelination in higher brain functions. Neural Plast. 2018(6436453)2018.PubMed/NCBI View Article : Google Scholar | |
|
Schwartz G and Fehlings MG: Secondary injury mechanisms of spinal cord trauma: A novel therapeutic approach for the management of secondary pathophysiology with the sodium channel blocker riluzole. Prog Brain Res. 137:177–190. 2002.PubMed/NCBI View Article : Google Scholar | |
|
Zhang Y, Al Mamun A, Yuan Y, Lu Q, Xiong J, Yang S, Wu C, Wu Y and Wang J: Acute spinal cord injury: Pathophysiology and pharmacological intervention (Review). Mol Med Rep. 23(417)2021.PubMed/NCBI View Article : Google Scholar | |
|
Sharma HS, Patnaik R, Sharma A, Sjöquist PO and Lafuente JV: Silicon dioxide nanoparticles (SiO2, 40-50 nm) exacerbate pathophysiology of traumatic spinal cord injury and deteriorate functional outcome in the rat. An experimental study using pharmacological and morphological approaches. J Nanosci Nanotechnol. 9:4970–4980. 2009.PubMed/NCBI View Article : Google Scholar | |
|
Dimitrijevic MR, Danner SM and Mayr W: Neurocontrol of movement in humans with spinal cord injury. Artif Organs. 39:823–833. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Zhang JX, Wang R, Xi J, Shen L, Zhu AY, Qi Q, Wang QY, Zhang LJ, Wang FC, Lü HZ and Hu JG: Morroniside protects SK-N-SH human neuroblastoma cells against H2O2-induced damage. Int J Mol Med. 39:603–612. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Leal-Filho MB: Spinal cord injury: From inflammation to glial scar. Surg Neurol Int. 2(112)2011.PubMed/NCBI View Article : Google Scholar | |
|
Yang T, Xing L, Yu W, Cai Y, Cui S and Chen G: Astrocytic reprogramming combined with rehabilitation strategy improves recovery from spinal cord injury. FASEB J. 34:15504–15515. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Lee-Liu D, Edwards-Faret G, Tapia VS and Larraín J: Spinal cord regeneration: Lessons for mammals from non-mammalian vertebrates. Genesis. 51:529–544. 2013.PubMed/NCBI View Article : Google Scholar | |
|
Yılmaz T and Kaptanoğlu E: Current and future medical therapeutic strategies for the functional repair of spinal cord injury. World J Orthop. 6:42–55. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Ahuja CS, Nori S, Tetreault L, Wilson J, Kwon B, Harrop J, Choi D and Fehlings MG: Traumatic spinal cord injury-repair and regeneration. Neurosurgery. 80 (3S):S9–S22. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Sabapathy V, Tharion G and Kumar S: Cell therapy augments functional recovery subsequent to spinal cord injury under experimental conditions. Stem Cells Int. 2015(132172)2015.PubMed/NCBI View Article : Google Scholar | |
|
Yousefifard M, Rahimi-Movaghar V, Nasirinezhad F, Baikpour M, Safari S, Saadat S, Moghadas Jafari A, Asady H, Razavi Tousi SM and Hosseini M: Neural stem/progenitor cell transplantation for spinal cord injury treatment; A systematic review and meta-analysis. Neuroscience. 322:377–397. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Ide C and Kanekiyo K: Points regarding cell transplantation for the treatment of spinal cord injury. Neural Regen Res. 11:1046–1049. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Lin XY, Lai BQ, Zeng X, Che MT, Ling EA, Wu W and Zeng YS: Cell transplantation and neuroengineering approach for spinal cord injury treatment: A summary of current laboratory findings and review of literature. Cell Transplant. 25:1425–1438. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Dumont CM, Margul DJ and Shea LD: Tissue engineering approaches to modulate the inflammatory milieu following spinal cord injury. Cells Tissues Organs. 202:52–66. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Raspa A, Pugliese R, Maleki M and Gelain F: Recent therapeutic approaches for spinal cord injury. Biotechnol Bioeng. 113:253–259. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Gradišnik L, Bošnjak R, Maver T and Velnar T: Advanced bio-based polymers for astrocyte cell models. Materials (Basel). 14(3664)2021.PubMed/NCBI View Article : Google Scholar | |
|
Orr MB and Gensel JC: Spinal cord injury scarring and inflammation: Therapies targeting glial and inflammatory responses. Neurotherapeutics. 15:541–553. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Beck KD, Nguyen HX, Galvan MD, Salazar DL, Woodruff TM and Anderson AJ: Quantitative analysis of cellular inflammation after traumatic spinal cord injury: Evidence for a multiphasic inflammatory response in the acute to chronic environment. Brain. 133:433–447. 2010.PubMed/NCBI View Article : Google Scholar | |
|
Buss A, Pech K, Kakulas BA, Martin D, Schoenen J, Noth J and Brook GA: Growth-modulating molecules are associated with invading Schwann cells and not astrocytes in human traumatic spinal cord injury. Brain. 130:940–953. 2007.PubMed/NCBI View Article : Google Scholar | |
|
Zhang SX, Huang F, Gates M and Holmberg EG: Role of endogenous Schwann cells in tissue repair after spinal cord injury. Neural Regen Res. 8:177–185. 2013.PubMed/NCBI View Article : Google Scholar | |
|
Tran AP, Warren PM and Silver J: The biology of regeneration failure and success after spinal cord injury. Physiol Rev. 98:881–917. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Adams KL and Gallo V: The diversity and disparity of the glial scar. Nat Neurosci. 21:9–15. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Pang QM, Chen SY, Xu QJ, Fu SP, Yang YC, Zou WH, Zhang M, Liu J, Wan WH, Peng JC and Zhang T: Neuroinflammation and scarring after spinal cord injury: Therapeutic roles of MSCs on inflammation and glial scar. Front Immunol. 12(751021)2021.PubMed/NCBI View Article : Google Scholar | |
|
Silver J and Miller JH: Regeneration beyond the glial scar. Nat Rev Neurosci. 5:146–156. 2004.PubMed/NCBI View Article : Google Scholar | |
|
Bradbury EJ, Moon LD, Popat RJ, King VR, Bennett GS, Patel PN, Fawcett JW and McMahon SB: Chondroitinase ABC promotes functional recovery after spinal cord injury. Nature. 416:636–640. 2002.PubMed/NCBI View Article : Google Scholar | |
|
Diaz Quiroz JF and Echeverri K: Spinal cord regeneration: Where fish, frogs and salamanders lead the way, can we follow? Biochem J. 451:353–364. 2013.PubMed/NCBI View Article : Google Scholar | |
|
Okada S, Nakamura M, Katoh H, Miyao T, Shimazaki T, Ishii K, Yamane J, Yoshimura A, Iwamoto Y, Toyama Y and Okano H: Conditional ablation of Stat3 or Socs3 discloses a dual role for reactive astrocytes after spinal cord injury. Nat Med. 12:829–834. 2006.PubMed/NCBI View Article : Google Scholar | |
|
Herrmann JE, Imura T, Song B, Qi J, Ao Y, Nguyen TK, Korsak RA, Takeda K, Akira S and Sofroniew MV: STAT3 is a critical regulator of astrogliosis and scar formation after spinal cord injury. J Neurosci. 28:7231–7243. 2008.PubMed/NCBI View Article : Google Scholar | |
|
Sofroniew MV: Astrocyte barriers to neurotoxic inflammation. Nat Rev Neurosci. 16:249–263. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Yang T, Dai Y, Chen G and Cui S: Dissecting the dual role of the glial scar and scar-forming astrocytes in spinal cord injury. Front Cell Neurosci. 14(78)2020.PubMed/NCBI View Article : Google Scholar | |
|
Sofroniew MV: Dissecting spinal cord regeneration. Nature. 557:343–350. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Wang L, Pei S, Han L, Guo B, Li Y, Duan R, Yao Y, Xue B, Chen X and Jia Y: Mesenchymal stem cell-derived exosomes reduce A1 astrocytes via downregulation of phosphorylated NFκB P65 subunit in spinal cord injury. Cell Physiol Biochem. 50:1535–1559. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Alvarez-Buylla A and Lim DA: For the long run: Maintaining germinal niches in the adult brain. Neuron. 41:683–686. 2004.PubMed/NCBI View Article : Google Scholar | |
|
Ming GL and Song H: Adult neurogenesis in the mammalian brain: Significant answers and significant questions. Neuron. 70:687–702. 2011.PubMed/NCBI View Article : Google Scholar | |
|
Horner PJ, Power AE, Kempermann G, Kuhn HG, Palmer TD, Winkler J, Thal LJ and Gage FH: Proliferation and differentiation of progenitor cells throughout the intact adult rat spinal cord. J Neurosci. 20:2218–2228. 2000.PubMed/NCBI View Article : Google Scholar | |
|
Borst K, Dumas AA and Prinz M: Microglia: Immune and non-immune functions. Immunity. 54:2194–2208. 2021.PubMed/NCBI View Article : Google Scholar | |
|
Park JH, Cho JH, Ahn JH, Choi SY, Lee TK, Lee JC, Shin BN, Hong S, Jeon YH, Kim YM, et al: Neuronal loss and gliosis in the rat striatum subjected to 15 and 30 min of middle cerebral artery occlusion. Metab Brain Dis. 33:775–784. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Lee Y, Lee SR, Choi SS, Yeo HG, Chang KT and Lee HJ: Therapeutically targeting neuroinflammation and microglia after acute ischemic stroke. Biomed Res Int. 2014(297241)2014.PubMed/NCBI View Article : Google Scholar | |
|
Wolf SA, Boddeke HWGM and Kettenmann H: Microglia in physiology and disease. Annu Rev Physiol. 79:619–643. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Savage JC, Carrier M and Tremblay MÈ: Morphology of microglia across contexts of health and disease. Methods Mol Biol. 2034:13–26. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Brown GC: Neuronal loss after stroke due to microglial phagocytosis of stressed neurons. Int J Mol Sci. 22(13442)2021.PubMed/NCBI View Article : Google Scholar | |
|
Mothe AJ and Tator CH: Proliferation, migration, and differentiation of endogenous ependymal region stem/progenitor cells following minimal spinal cord injury in the adult rat. Neuroscience. 131:177–187. 2005.PubMed/NCBI View Article : Google Scholar | |
|
Park JH, Kim DY, Sung IY, Choi GH, Jeon MH, Kim KK and Jeon SR: Long-term results of spinal cord injury therapy using mesenchymal stem cells derived from bone marrow in humans. Neurosurgery. 70:1238–1247. 2012.PubMed/NCBI View Article : Google Scholar | |
|
Lima C, Escada P, Pratas-Vital J, Branco C, Arcangeli CA, Lazzeri G, Maia CA, Capucho C, Hasse-Ferreira A and Peduzzi JD: Olfactory mucosal autografts and rehabilitation for chronic traumatic spinal cord injury. Neurorehabil Neural Repair. 24:10–22. 2010.PubMed/NCBI View Article : Google Scholar | |
|
Saberi H, Firouzi M, Habibi Z, Moshayedi P, Aghayan HR, Arjmand B, Hosseini K, Razavi HE and Yekaninejad MS: Safety of intramedullary Schwann cell transplantation for postrehabilitation spinal cord injuries: 2-Year follow-up of 33 cases. J Neurosurg Spine. 15:515–525. 2011.PubMed/NCBI View Article : Google Scholar | |
|
Ronaghi M, Erceg S, Moreno-Manzano V and Stojkovic M: Challenges of stem cell therapy for spinal cord injury: Human embryonic stem cells, endogenous neural stem cells, or induced pluripotent stem cells? Stem Cells. 28:93–99. 2010.PubMed/NCBI View Article : Google Scholar | |
|
Osaka M, Honmou O, Murakami T, Nonaka T, Houkin K, Hamada H and Kocsis JD: Intravenous administration of mesenchymal stem cells derived from bone marrow after contusive spinal cord injury improves functional outcome. Brain Res. 1343:226–235. 2010.PubMed/NCBI View Article : Google Scholar | |
|
Chhabra HS, Lima C, Sachdeva S, Mittal A, Nigam V, Chaturvedi D, Arora M, Aggarwal A, Kapur R and Khan TAH: Autologous olfactory [corrected] mucosal transplant in chronic spinal cord injury: An Indian pilot study. Spinal Cord. 47:887–895. 2009.PubMed/NCBI View Article : Google Scholar | |
|
Liu C, Chen Z, Chen Z, Zhang T and Lu Y: Multiple tumor types may originate from bone marrow-derived cells. Neoplasia. 8:716–724. 2006.PubMed/NCBI View Article : Google Scholar | |
|
Tolar J, Nauta AJ, Osborn MJ, Panoskaltsis Mortari A, McElmurry RT, Bell S, Xia L, Zhou N, Riddle M, Schroeder TM, et al: Sarcoma derived from cultured mesenchymal stem cells. Stem Cells. 25:371–379. 2007.PubMed/NCBI View Article : Google Scholar | |
|
Wu Z, Parry M, Hou XY, Liu MH, Wang H, Cain R, Pei ZF, Chen YC, Guo ZY, Abhijeet S and Chen G: Gene therapy conversion of striatal astrocytes into GABAergic neurons in mouse models of Huntington's disease. Nat Commun. 11(1105)2020.PubMed/NCBI View Article : Google Scholar | |
|
Chen YC, Ma NX, Pei ZF, Wu Z, Do-Monte FH, Keefe S, Yellin E, Chen MS, Yin JC, Lee G, et al: A NeuroD1 AAV-based gene therapy for functional brain repair after ischemic injury through in vivo astrocyte-to-neuron conversion. Mol Ther. 28:217–234. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Li H and Chen G: In vivo reprogramming for CNS repair: Regenerating neurons from endogenous glial cells. Neuron. 91:728–738. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Guo Z, Zhang L, Wu Z, Chen Y, Wang F and Chen G: In vivo direct reprogramming of reactive glial cells into functional neurons after brain injury and in an Alzheimer's disease model. Cell Stem Cell. 14:188–202. 2014.PubMed/NCBI View Article : Google Scholar | |
|
Hemmings BA, Yellowlees D, Kernohan JC and Cohen P: Purification of glycogen synthase kinase 3 from rabbit skeletal muscle. Copurification with the activating factor (FA) of the (Mg-ATP) dependent protein phosphatase. Eur J Biochem. 119:443–451. 1981.PubMed/NCBI View Article : Google Scholar | |
|
Jope RS: Lithium and GSK-3: One inhibitor, two inhibitory actions, multiple outcomes. Trends Pharmacol Sci. 24:441–443. 2003.PubMed/NCBI View Article : Google Scholar | |
|
Hur EM and Zhou FQ: GSK3 signalling in neural development. Nat Rev Neurosci. 11:539–551. 2010.PubMed/NCBI View Article : Google Scholar | |
|
Force T and Woodgett JR: Unique and overlapping functions of GSK-3 isoforms in cell differentiation and proliferation and cardiovascular development. J Biol Chem. 284:9643–9647. 2009.PubMed/NCBI View Article : Google Scholar | |
|
Grimes CA and Jope RS: CREB DNA binding activity is inhibited by glycogen synthase kinase-3 beta and facilitated by lithium. J Neurochem. 78:1219–1232. 2001.PubMed/NCBI View Article : Google Scholar | |
|
Neal JW and Clipstone NA: Glycogen synthase kinase-3 inhibits the DNA binding activity of NFATc. J Biol Chem. 276:3666–3673. 2001.PubMed/NCBI View Article : Google Scholar | |
|
Ma YC, Song MR, Park JP, Henry Ho HY, Hu L, Kurtev MV, Zieg J, Ma Q, Pfaff SL and Greenberg ME: Regulation of motor neuron specification by phosphorylation of neurogenin 2. Neuron. 58:65–77. 2008.PubMed/NCBI View Article : Google Scholar | |
|
Fuentealba LC, Eivers E, Ikeda A, Hurtado C, Kuroda H, Pera EM and De Robertis EM: Integrating patterning signals: Wnt/GSK3 regulates the duration of the BMP/Smad1 signal. Cell. 131:980–993. 2007.PubMed/NCBI View Article : Google Scholar | |
|
Kazi A, Xiang S, Yang H, Delitto D, Trevino J, Jiang RHY, Ayaz M, Lawrence HR, Kennedy P and Sebti SM: GSK3 suppression upregulates β-catenin and c-Myc to abrogate KRas-dependent tumors. Nat Commun. 9(5154)2018.PubMed/NCBI View Article : Google Scholar | |
|
Linding R, Jensen LJ, Ostheimer GJ, van Vugt MA, Jørgensen C, Miron IM, Diella F, Colwill K, Taylor L, Elder K, et al: Systematic discovery of in vivo phosphorylation networks. Cell. 129:1415–1426. 2007.PubMed/NCBI View Article : Google Scholar | |
|
Beurel E, Grieco SF and Jope RS: Glycogen synthase kinase-3 (GSK3): Regulation, actions, and diseases. Pharmacol Ther. 148:114–131. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Mancinelli R, Carpino G, Petrungaro S, Mammola CL, Tomaipitinca L, Filippini A, Facchiano A, Ziparo E and Giampietri C: Multifaceted roles of GSK-3 in cancer and autophagy-related diseases. Oxid Med Cell Longev. 2017(4629495)2017.PubMed/NCBI View Article : Google Scholar | |
|
Jaworski T, Banach-Kasper E and Gralec K: GSK-3 β at the intersection of neuronal plasticity and neurodegeneration. Neural Plast. 2019(4209475)2019.PubMed/NCBI View Article : Google Scholar | |
|
Hernandez F, Lucas JJ and Avila J: GSK3 and tau: Two convergence points in Alzheimer's disease. J Alzheimers Dis. 33 (Suppl 1):S141–S144. 2013.PubMed/NCBI View Article : Google Scholar | |
|
Albeely AM, Ryan SD and Perreault ML: Pathogenic feed-forward mechanisms in Alzheimer's and Parkinson's disease converge on GSK-3. Brain Plast. 4:151–167. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Manduca JD, Thériault RK and Perreault ML: Glycogen synthase kinase-3: The missing link to aberrant circuit function in disorders of cognitive dysfunction? Pharmacol Res. 157(104819)2020.PubMed/NCBI View Article : Google Scholar | |
|
Wu YY, Wang X, Tan L, Liu D, Liu XH, Wang Q, Wang JZ and Zhu LQ: Lithium attenuates scopolamine-induced memory deficits with inhibition of GSK-3β and preservation of postsynaptic components. J Alzheimers Dis. 37:515–527. 2013.PubMed/NCBI View Article : Google Scholar | |
|
Kozlovsky N, Belmaker RH and Agam G: Low GSK-3 activity in frontal cortex of schizophrenic patients. Schizophr Res. 52:101–105. 2001.PubMed/NCBI View Article : Google Scholar | |
|
Kozlovsky N, Shanon-Weickert C, Tomaskovic-Crook E, Kleinman JE, Belmaker RH and Agam G: Reduced GSK-3beta mRNA levels in postmortem dorsolateral prefrontal cortex of schizophrenic patients. J Neural Transm (Vienna). 111:1583–1592. 2004.PubMed/NCBI View Article : Google Scholar | |
|
Besing RC, Rogers CO, Paul JR, Hablitz LM, Johnson RL, McMahon LL and Gamble KL: GSK3 activity regulates rhythms in hippocampal clock gene expression and synaptic plasticity. Hippocampus. 27:890–898. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Mao Y, Ge X, Frank CL, Madison JM, Koehler AN, Doud MK, Tassa C, Berry EM, Soda T, Singh KK, et al: Disrupted in schizophrenia 1 regulates neuronal progenitor proliferation via modulation of GSK3beta/beta-catenin signaling. Cell. 136:1017–1031. 2009.PubMed/NCBI View Article : Google Scholar | |
|
Morales-Garcia JA, Luna-Medina R, Alonso-Gil S, Sanz-Sancristobal M, Palomo V, Gil C, Santos A, Martinez A and Perez-Castillo A: Glycogen synthase kinase 3 inhibition promotes adult hippocampal neurogenesis in vitro and in vivo. ACS Chem Neurosci. 3:963–971. 2012.PubMed/NCBI View Article : Google Scholar | |
|
Lange C, Mix E, Frahm J, Glass A, Müller J, Schmitt O, Schmöle AC, Klemm K, Ortinau S, Hübner R, et al: Small molecule GSK-3 inhibitors increase neurogenesis of human neural progenitor cells. Neurosci Lett. 488:36–40. 2011.PubMed/NCBI View Article : Google Scholar | |
|
Lie DC, Colamarino SA, Song HJ, Désiré L, Mira H, Consiglio A, Lein ES, Jessberger S, Lansford H, Dearie AR and Gage FH: Wnt signalling regulates adult hippocampal neurogenesis. Nature. 437:1370–1375. 2005.PubMed/NCBI View Article : Google Scholar | |
|
Wexler EM, Geschwind DH and Palmer TD: Lithium regulates adult hippocampal progenitor development through canonical Wnt pathway activation. Mol Psychiatry. 13:285–292. 2008.PubMed/NCBI View Article : Google Scholar | |
|
Kim WY, Wang X, Wu Y, Doble BW, Patel S, Woodgett JR and Snider WD: GSK-3 is a master regulator of neural progenitor homeostasis. Nat Neurosci. 12:1390–1397. 2009.PubMed/NCBI View Article : Google Scholar | |
|
Rashvand M, Danyali S and Manaheji H: The potential role of glycogen synthase kinase-3β in neuropathy-induced apoptosis in spinal cord. Basic Clin Neurosci. 11:15–30. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Bareiss SK, Dugan E and Brewer KL: PI3K mediated activation of GSK-3β reduces at-level primary afferent growth responses associated with excitotoxic spinal cord injury dysesthesias. Mol Pain. 11(35)2015.PubMed/NCBI View Article : Google Scholar | |
|
Rodriguez-Jimenez FJ, Vilches A, Perez-Arago MA, Clemente E, Roman R, Leal J, Castro AA, Fustero S, Moreno-Manzano V, Jendelova P, et al: Activation of neurogenesis in multipotent stem cells cultured in vitro and in the spinal cord tissue after severe injury by inhibition of glycogen synthase kinase-3. Neurotherapeutics. 18:515–533. 2021.PubMed/NCBI View Article : Google Scholar | |
|
Lei F, He W, Tian X, Zhou Q, Zheng L, Kang J, Song Y and Feng D: GSK-3 inhibitor promotes neuronal cell regeneration and functional recovery in a rat model of spinal cord injury. Biomed Res Int. 2019(9628065)2019.PubMed/NCBI View Article : Google Scholar | |
|
Zhang G, Lei F, Zhou Q, Feng D and Bai Y: Combined application of Rho-ROCKII and GSK-3β inhibitors exerts an improved protective effect on axonal regeneration in rats with spinal cord injury. Mol Med Rep. 14:5180–5188. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Burgess S, Geddes J, Hawton K, Townsend E, Jamison K and Goodwin G: Lithium for maintenance treatment of mood disorders. Cochrane Database Syst Rev. (CD003013)2001.PubMed/NCBI View Article : Google Scholar | |
|
Young W: Review of lithium effects on brain and blood. Cell Transplant. 18:951–975. 2009.PubMed/NCBI View Article : Google Scholar | |
|
Li B, Ren J, Yang L, Li X, Sun G and Xia M: Lithium inhibits GSK3β activity via two different signaling pathways in neurons after spinal cord injury. Neurochem Res. 43:848–856. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Pan Z, Oh J, Huang L, Zeng Z, Duan P, Li Z, Yun Y, Kim J, Ha Y and Cao K: The combination of forskolin and VPA increases gene expression efficiency to the hypoxia/neuron-specific system. Ann Transl Med. 8(933)2020.PubMed/NCBI View Article : Google Scholar | |
|
Li Z, Wu F, Zhang X, Chai Y, Chen D, Yang Y, Xu K, Yin J, Li R, Shi H, et al: Valproate attenuates endoplasmic reticulum stress-induced apoptosis in SH-SY5Y cells via the AKT/GSK3β signaling pathway. Int J Mol Sci. 18(315)2017.PubMed/NCBI View Article : Google Scholar | |
|
Zhou Y, Wang Z, Li J, Li X and Xiao J: Fibroblast growth factors in the management of spinal cord injury. J Cell Mol Med. 22:25–37. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Rabchevsky AG, Fugaccia I, Turner AF, Blades DA, Mattson MP and Scheff SW: Basic fibroblast growth factor (bFGF) enhances functional recovery following severe spinal cord injury to the rat. Exp Neurol. 164:280–291. 2000.PubMed/NCBI View Article : Google Scholar | |
|
Rabchevsky AG, Fugaccia I, Fletcher-Turner A, Blades DA, Mattson MP and Scheff SW: Basic fibroblast growth factor (bFGF) enhances tissue sparing and functional recovery following moderate spinal cord injury. J Neurotrauma. 16:817–830. 1999.PubMed/NCBI View Article : Google Scholar | |
|
Sisakht M, Khoshdel Z, Mahmoodazdeh A, Shafiee SM and Takhshid MA: Adrenomedullin increases cAMP accumulation and BDNF expression in rat DRG and spinal motor neurons. Iran J Basic Med Sci. 24:978–985. 2021.PubMed/NCBI View Article : Google Scholar | |
|
Fu J, Sun H, Wei H, Dong M, Zhang Y, Xu W, Fang Y and Zhao J: Astaxanthin alleviates spinal cord ischemia-reperfusion injury via activation of PI3K/Akt/GSK-3β pathway in rats. J Orthop Surg Res. 15(275)2020.PubMed/NCBI View Article : Google Scholar | |
|
Ding Y, Xia S, Fang H, Niu B and Chen Q: Loureirin B attenuates insulin resistance in HepG2 cells by regulating gluconeogenesis signaling pathway. Eur J Pharmacol. 910(174481)2021.PubMed/NCBI View Article : Google Scholar | |
|
Shi S, Zhao Q, Ke C, Long S, Zhang F, Zhang X, Li Y, Liu X, Hu H and Yin S: Loureirin B exerts its immunosuppressive effects by inhibiting STIM1/Orai1 and KV1.3 channels. Front Pharmacol. 12(685092)2021.PubMed/NCBI View Article : Google Scholar | |
|
Wang Q, Cai H, Hu Z, Wu Y, Guo X, Li J, Wang H, Liu Y, Liu Y, Xie L, et al: Loureirin B promotes axon regeneration by inhibiting endoplasmic reticulum stress: Induced mitochondrial dysfunction and regulating the Akt/GSK-3β pathway after spinal cord injury. J Neurotrauma. 36:1949–1964. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Yousefifard M, Nasirinezhad F, Shardi Manaheji H, Janzadeh A, Hosseini M and Keshavarz M: Human bone marrow-derived and umbilical cord-derived mesenchymal stem cells for alleviating neuropathic pain in a spinal cord injury model. Stem Cell Res Ther. 7(36)2016.PubMed/NCBI View Article : Google Scholar | |
|
Schieweck R, Schöneweiss EC, Harner M, Rieger D, Illig C, Saccà B, Popper B and Kiebler MA: Pumilio2 promotes growth of mature neurons. Int J Mol Sci. 22(8998)2021.PubMed/NCBI View Article : Google Scholar | |
|
Huang F, Gao T, Wang W, Wang L, Xie Y, Tai C, Liu S, Cui Y and Wang B: Engineered basic fibroblast growth factor-overexpressing human umbilical cord-derived mesenchymal stem cells improve the proliferation and neuronal differentiation of endogenous neural stem cells and functional recovery of spinal cord injury by activating the PI3K-Akt-GSK-3β signaling pathway. Stem Cell Res Ther. 12(468)2021.PubMed/NCBI View Article : Google Scholar | |
|
New PW, Lim TC, Hill ST and Brown DJ: A survey of pain during rehabilitation after acute spinal cord injury. Spinal Cord. 35:658–663. 1997.PubMed/NCBI View Article : Google Scholar | |
|
Störmer S, Gerner HJ, Grüninger W, Metzmacher K, Föllinger S, Wienke C, Aldinger W, Walker N, Zimmermann M and Paeslack V: Chronic pain/dysaesthesiae in spinal cord injury patients: Results of a multicentre study. Spinal Cord. 35:446–455. 1997.PubMed/NCBI View Article : Google Scholar | |
|
Peng Z, Zha L, Yang M, Li Y, Guo X and Feng Z: Effects of ghrelin on pGSK-3β and β-catenin expression when protects against neuropathic pain behavior in rats challenged with chronic constriction injury. Sci Rep. 9(14664)2019.PubMed/NCBI View Article : Google Scholar | |
|
Sarveazad A, Janzadeh A, Taheripak G, Dameni S, Yousefifard M and Nasirinezhad F: Co-administration of human adipose-derived stem cells and low-level laser to alleviate neuropathic pain after experimental spinal cord injury. Stem Cell Res Ther. 10(183)2019.PubMed/NCBI View Article : Google Scholar | |
|
Parkitna JR, Obara I, Wawrzczak-Bargiela A, Makuch W, Przewlocka B and Przewlocki R: Effects of glycogen synthase kinase 3beta and cyclin-dependent kinase 5 inhibitors on morphine-induced analgesia and tolerance in rats. J Pharmacol Exp Ther. 319:832–839. 2006.PubMed/NCBI View Article : Google Scholar | |
|
Wang X, Lin C, Jin S, Wang Y, Peng Y and Wang X: Cannabidiol alleviates neuroinflammation and attenuates neuropathic pain via targeting FKBP5. Brain Behav Immun. 111:365–375. 2023.PubMed/NCBI View Article : Google Scholar | |
|
Xu W, Zhu M, Yuan S and Yu W: Spinal CXCL5 contributes to nerve injury-induced neuropathic pain via modulating GSK-3β phosphorylation and activity in rats. Neurosci Lett. 634:52–59. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Chen JY, Chu LW, Cheng KI, Hsieh SL, Juan YS and Wu BN: Valproate reduces neuroinflammation and neuronal death in a rat chronic constriction injury model. Sci Rep. 8(16457)2018.PubMed/NCBI View Article : Google Scholar | |
|
Cheng H, Zhang L, Xia F, Jin L, Liu S, Ren H, Zhu C, Ji Q and Tang J: Astrocytic NDRG2 is critical in the maintenance of neuropathic pain. Brain Behav Immun. 89:300–313. 2020.PubMed/NCBI View Article : Google Scholar |
